Skip to content
primarysourced Photonics sector POET
POET
~1 min read · 321 words ·updated 2026-04-29 · ⚠ speculative

POET Technologies — thesis section

This section contains the analyst-curated long-form thesis on POET Technologies (NASDAQ: POET, TSX: PTK). Each file isolates one dimension of the investment view so a reader can audit the structure of the call independently of any narrative framing.

POET sits in an unusual valuation regime: a microcap with a real, peer-reviewed-validated technical platform (the Optical Interposer) shipping ~$1M of revenue against ~$300M of accumulated deficit and a fresh ~$430M cash balance after dilutive late-2025/early-2026 raises. The thesis files below treat that asymmetry honestly — neither dismissing the technical optionality nor underweighting the dilution and execution-risk overhangs that have defined the equity since at least the 2016 DenseLight acquisition.

Files

  • Bull case — five-pillar thesis: the testable positive case (Optical Interposer cost structure, foundry-light manufacturing, light-source partnership stack, AI-pluggable TAM growth, microcap-to-revenue-ramp leverage). Each pillar carries a “what would invalidate” testable signal.
  • Bear case — dilution-trajectory and execution-risk thesis: the testable negative case (capital structure deterioration, “nearly there since 2018” execution narrative, NDA-shielded customer base, JV-history-as-pattern, monolithic-SiPh competitive overhang).
  • Risk register — seven categories: structured Likelihood × Impact register across Technical, Customer, Foundry, Capital, IP, Competitive, and Market dimensions. Mirrors the MRVL risk register structure.
  • Forward catalyst calendar: near-term (next 6-K, AGM, Q1 2026 earnings), mid-term (FY26 20-F, OFC 2026, ECOC 2026), long-term (1.6T/3.2T product cycle, hyperscaler customer name).
  • Open research questions: 8-10 questions POET has not publicly answered, with research path + current best-guess + confidence flag.

Cross-references